Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:1105-1110

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Régrigny, O.
Right arrow Articles by Chillon, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Régrigny, O.
Right arrow Articles by Chillon, J.-M.
Related Collections
Right arrow Remodeling
Right arrow Cerebrovascular disease/stroke
Right arrow Hypertrophy

(Hypertension. 2000;35:1105.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Effect of Lovastatin on Cerebral Circulation in Spontaneously Hypertensive Rats

Olivier Régrigny; Jeffrey Atkinson; Christine Capdeville-Atkinson; Patrick Limiñana; Jean-Marc Chillon

From the Laboratoire de Pharmacologie Cardiovasculaire (O.R., J.A., C.C.-A., P.L., J.-M.C.), Faculté de Pharmacie, Nancy, France.

Correspondence to Jeffrey Atkinson, PhD, Laboratoire de Pharmacologie Cardiovasculaire, Faculté de Pharmacie, UHP—Nancy 1, 5, rue Albert Lebrun, BP 403, 54000 Nancy, France. E-mail atkinson{at}pharma.u-nancy.fr

Abstract—Statins, which are often given to hypertensive patients, reduce the incidence of stroke. However, their effects on the cerebral circulation have been scarcely studied, although lovastatin has been reported to reduce hypertension-induced renal arteriolar hypertrophy. We examined the structure and mechanics of cerebral arterioles and the lower limit of cerebral blood flow (CBF) autoregulation in spontaneously hypertensive rats (SHR) that were untreated (n=9) or treated for 1 month with lovastatin (n=12; 20 mg · kg-1 · d-1) and in untreated Wistar-Kyoto rats (WKY; n=8). We studied the lower limit of CBF autoregulation by repeated measurement of CBF (arbitrary units; laser Doppler) and internal arteriolar diameter (µm; cranial window) at baseline and during stepwise hypotension. Stress-strain relationships were calculated from repeated measurement of internal arteriolar diameter during stepwise hypotension and cross-sectional area (CSA) of the vessel wall in maximally dilated cerebral arterioles (EDTA, 67 mmol/L). Lovastatin slightly reduced mean arterial pressure (treated, 153±3 versus untreated, 171±5 mm Hg, P<0.05; WKY, 106±3 mm Hg) and normalized CSA (treated, 826±52 versus untreated, 1099±16 µm2, P<0.05; WKY, 774±28 µm2). Stress-strain curves show that lovastatin also attenuated the increase in passive distensibility. Lovastatin had no effect on the external diameter of cerebral arterioles or the lower limit of CBF autoregulation. Our results show that although lovastatin has substantial effects on arteriolar mechanics and wall CSA, it has little effect on internal diameter. This phenomenon may explain its lack of effect on CBF autoregulation.


Key Words: hypertrophy • remodeling • inhibitors, HMG-CoA reductase • autoregulation




This article has been cited by other articles:


Home page
HypertensionHome page
S. Delbosc, J.-P. Cristol, B. Descomps, A. Mimran, and B. Jover
Simvastatin Prevents Angiotensin II-Induced Cardiac Alteration and Oxidative Stress
Hypertension, August 1, 2002; 40(2): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M Lefer, R. Scalia, and D. J Lefer
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease
Cardiovasc Res, February 1, 2001; 49(2): 281 - 287.
[Full Text] [PDF]